ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,469.30
0.39%
US Tech 100
19,175.20
0.00%
다우존스 지수
39,112.16
-0.76%
Bitcoin
61,719.43
-0.15%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Therapeutics Acquisition Corp (TXAC)

  7. Therapeutics Acquisition Corp (TXAC) 뉴스

TXAC

Therapeutics Acquisition (TXAC)

Therapeutics Acquisition Corp
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TXAC
일자시간출처헤드라인심볼기업
2023/06/1507:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2023/06/1507:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TXACTherapeutics Acquisition Corp
2023/06/0606:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2023/06/0606:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2023/06/0606:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2023/06/0606:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2023/06/0606:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2023/06/0605:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
2023/05/0202:58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:TXACTherapeutics Acquisition Corp
2023/04/2721:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TXACTherapeutics Acquisition Corp
2023/03/2720:55Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TXACTherapeutics Acquisition Corp
2023/02/1502:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TXACTherapeutics Acquisition Corp
2023/02/0722:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
2023/02/0402:12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TXACTherapeutics Acquisition Corp
2022/11/2908:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2022/11/2908:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2022/11/2908:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2022/11/2402:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2022/11/2306:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TXACTherapeutics Acquisition Corp
2022/11/2207:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
2022/11/1421:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TXACTherapeutics Acquisition Corp
2022/09/2706:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TXACTherapeutics Acquisition Corp
2022/09/2705:55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TXACTherapeutics Acquisition Corp
2022/09/1705:30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TXACTherapeutics Acquisition Corp
2022/09/1505:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
2022/09/1505:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TXACTherapeutics Acquisition Corp
2022/09/1405:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
2022/09/1220:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
2022/09/0621:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
2022/08/3006:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TXACTherapeutics Acquisition Corp
 검색 관련기사 보기:NASDAQ:TXAC

최근 히스토리

NYSE
MRK
Merck
SPI
SP500
S&P 500
NASDAQ
GOOGL
Alphabet
AMEX
SPY
SPDR S&P 500
CCOM
US30
US 30
USOTC
RHHBY
Roche (QX)
FX
USDJPY
US Dollar vs Yen
COIN
BTCUSD
Bitcoin
CCOM
US100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
NYSE
VZ
Verizon Communications
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유